NHS Logo

Hemolytic uremic syndrome : (Record no. 92089)

MARC details
000 -LEADER
fixed length control field 04145cam a2200625 i 4500
001 - CONTROL NUMBER
control field ocn899279901
003 - CONTROL NUMBER IDENTIFIER
control field OCoLC
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20240729131815.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION
fixed length control field m d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr |||||||||||
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 140923s2015 nyu ob 001 0 eng
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER
LC control number 2020687203
040 ## - CATALOGING SOURCE
Original cataloging agency DLC
019 ## -
-- 914151426
-- 923677268
-- 928196480
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 9781634632461
Qualifying information ebook
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 163463246X
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Cancelled/invalid ISBN 9781634632270
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Cancelled/invalid ISBN 1634632273
035 ## - SYSTEM CONTROL NUMBER
System control number 940572
-- (N$T)
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)899279901
Canceled/invalid control number (OCoLC)914151426
-- (OCoLC)923677268
-- (OCoLC)928196480
060 #4 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number WH 170
072 #7 - SUBJECT CATEGORY CODE
Subject category code HEA
Subject category code subdivision 039000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 014000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 022000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 112000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 045000
Source bisacsh
049 ## - LOCAL HOLDINGS (OCLC)
Holding library MAIN
245 00 - TITLE STATEMENT
Title Hemolytic uremic syndrome :
Subtitle symptoms, treatment options, and prognosis
Statement of responsibility, etc
Medium [E-Book]
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture New York :
Name of producer, publisher, distributor, manufacturer Nova Biomedical,
Date of production, publication, distribution, manufacture, or copyright notice [2015]
300 ## - PHYSICAL DESCRIPTION
Physical description 1 online resource.
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier
490 1# - SERIES TITLE
Series statement Renal and urologic disorders
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references and index.
505 0# - CONTENTS
Contents Chapter I: The Role of Thrombin in Hemolytic Uremic Syndrome and Other Thrombotic Microangiopathies; Abstract; Introduction; 1. Thrombin Activation in EndothelialCell Physiology; 2. Modulation of Thrombin in TMAs; 3. Effects of Shiga Toxin on EndothelialCells and Thrombin Production; 4. Animal Models; 5. Treatments Targeting Thrombin in HUSand TMAs.
505 8# - CONTENTS
Contents 6. Inflammation and Thrombosis:Connections and ConvergenceConclusion; References -- Chapter II: Therapeutic Apheresis in Children with Renal Diseases, Especially Hemolytic Uremic Syndrome; Abstract; Introduction; Hemolytic-Uremic Syndrome (HUS); Rapidly Progressive Glomerulonephritis (RPGN); Anti-Basement Membrane Antibody Glomerulonephritis (Goodpasture Syndrome, ABM-ab-GN); Immune Complex Nephritis (ICN); RPGN with or without Glomerular Deposition (ANCA ab) Pauci-Immune RPGN; Therapy Recommendations for RPGN; Glomerulonephritis with Nephrotic Syndrome (NS); Myoglobulinemic Renal Failure.
505 8# - CONTENTS
Contents Acute Kidney Injury (AKI)Kidney Transplant Rejection; Summary; References -- Chapter III: The Consequences of Soliris�Therapy in Patients with aHUS; Abstract; Background; The Role of Complement in aHUS; Limitations of Supportive Care Options; Eculizumab; Treatment; Ethical Annotation; Conclusion; References -- Chapter IV: Hemolytic Uremic Syndrome: Overview and Update; Abstract; HUS is Classified Accordingto the Etiology into 3 Categories; Epidemiology; Symptoms; Extrarenal Complications; Pathogenesis; Diagnosis; Treatment Options; Prognosis; Conclusion; References; Blank Page; Index.
520 ## - ABSTRACT
Abstract Hemolytic uremic syndrome (HUS) is characterized by the triad non-immune micro-angiopathic hemolytic anemia, thrombocytopenia and acute renal failure. The disease mainly affects children one to ten years of age. It begins after an incubation period of 4 to 7 days with abrupt onset of bloody diarrhea and abdominal pain. Two to ten days later, microangiopathy, haemolytic anaemia, thrombocytopenia, and acute renal failure develop. HUS microangiopathy can involve almost any organ, but damage to kidneys and central nervous system cause the most severe clinical problems. This book discusses the symp.
590 ## - LOCAL NOTE (RLIN)
Local note Master record variable field(s) change: 050, 082
650 #0 - SUBJECT HEADINGS
Subject term Hemolytic-uremic syndrome.
650 #0 - SUBJECT HEADINGS
Subject term Kidneys
General subdivision Diseases.
650 12 - SUBJECT HEADINGS
Subject term Hemolytic-Uremic Syndrome.
650 22 - SUBJECT HEADINGS
Subject term Kidney Diseases.
700 1# - ADDED PERSONAL NAME
Added personal author Clayton, Glenna,
Relator term editor.
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Renal and urologic disorders.
856 ## - ONLINE RESOURCE
Uniform Resource Identifier <a href="#gotoholdings">#gotoholdings</a>
Link text Access resource
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Suppress in OPAC Do not Suppress in OPAC
588 ## - SOURCE OF DESCRIPTION NOTE
Source of description note Description based on print version record.
938 ## -
-- YBP Library Services
-- YANK
-- 12092714
938 ## -
-- EBSCOhost
-- EBSC
-- 940572
938 ## -
-- ebrary
-- EBRY
-- ebr10997880
938 ## -
-- ProQuest Ebook Central
-- EBLB
-- EBL2084866
994 ## -
-- 92
-- N$T
Holdings
Withdrawn status Lost status Damaged status Not for loan Home library Current library Shelving location Date acquired Source of acquisition Total Checkouts Date last seen Uniform Resource Identifier Price effective from Koha item type
        Stenhouse Library (Kingston Hospital) Stenhouse Library (Kingston Hospital) Online 28/11/2022 eBook EBSCO clinical collection   28/11/2022 https://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=940572 28/11/2022 Electronic book
London Health Libraries Consortium Privacy notice and Membership terms and conditions